LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 15

Search options

  1. Book: Sclerotherapy

    Guex, Jean-Jérôme / Goldman, Mitchel P. / Weiss, Robert A.

    treatment of varicose and telangiectatic leg veins

    (ExpertConsult.com)

    2017  

    Author's details editors, Mitchel P. Goldman, MD, Robert A. Weiss, MD ; contributors, Jean-Jérôme Guex, Hugo Partsch, Michel R. Perrin, Albert-Adrien Ramelet, Stefano Ricci, Oscar Maleti, Marzia Lugli
    Series title ExpertConsult.com
    Keywords Varicose Veins / therapy ; Sclerotherapy ; Telangiectasis / therapy
    Language English
    Size xiv, 444 Seiten, Illustrationen
    Edition Sixth edition
    Publisher Elsevier
    Publishing place New York, NY
    Publishing country United States
    Document type Book
    Accompanying material Zugang zu Online-Ausgabe über Code
    HBZ-ID HT019289206
    ISBN 978-0-323-37726-3 ; 9780323377287 ; 9780323377270 ; 0-323-37726-2 ; 0323377289 ; 0323377270
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Article: Clinical Perspectives and Management of Edema in Chronic Venous Disease-What about Ruscus?

    Bihari, Imre / Guex, Jean-Jérôme / Jawien, Arkadiusz / Szolnoky, Gyozo

    Medicines (Basel, Switzerland)

    2022  Volume 9, Issue 8

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2022-07-25
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2777965-8
    ISSN 2305-6320
    ISSN 2305-6320
    DOI 10.3390/medicines9080041
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Endovenous chemical (and physical) treatments for varices: what's new?

    Guex, Jean-Jérôme

    Phlebology

    2014  Volume 29, Issue 1 suppl, Page(s) 45–48

    Abstract: The constant evolution of endo-venous ablative techniques for varicose veins arises from the need for: better patient's comfort, reduced incidence of side effects, better results at short-, mid- and long-term follow-up, as well as reduction of operating ... ...

    Abstract The constant evolution of endo-venous ablative techniques for varicose veins arises from the need for: better patient's comfort, reduced incidence of side effects, better results at short-, mid- and long-term follow-up, as well as reduction of operating time and technical simplicity. All these goals have been aimed at but so far no new technology has been able to achieve them all or to demonstrate it, furthermore the increase of price must be compensated by a considerable improvement of results and a serious reduction of side effects to be incrementally cost effective. We present in this article several recent evolutions of sclerotherapy (chemical ablation). New technologies include: proprietary ready-made foam (Varithena®) foam sclerotherapy with catheter and tumescence, foam + Holmium laser (LAFOS®), liquid sclerosant with rotating wire (clarivein®), liquid sclerosant + endo-venous clip (V-Block®) and endovenous cyano-acrylate glue (Venaseal™).
    Language English
    Publishing date 2014-05
    Publishing country England
    Document type Review
    ZDB-ID 645172-x
    ISSN 1758-1125 ; 0268-3555
    ISSN (online) 1758-1125
    ISSN 0268-3555
    DOI 10.1177/0268355514526331
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Complications of sclerotherapy: an update.

    Guex, Jean-Jérôme

    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.

    2010  Volume 36 Suppl 2, Page(s) 1056–1063

    Abstract: Objectives: To describe, determine the incidence of, and explain the adverse reactions associated with the use of sclerotherapy and sclerosing agents.: Material and methods: Review of current literature and personal research, with special attention ... ...

    Abstract Objectives: To describe, determine the incidence of, and explain the adverse reactions associated with the use of sclerotherapy and sclerosing agents.
    Material and methods: Review of current literature and personal research, with special attention to the French registry of 12,173 sclerotherapy sessions.
    Results: The nature and incidence of side effects of sclerosing agents vary according to the injection form: liquid or foam. They must be differentiated from complications of the method, which are less specific and often related to an inappropriate technique. Severe adverse events are rare, especially in relation to the billions of injections administered.
    Conclusion: Complications and side effects of sclerotherapy are uncommon; the method has demonstrated its safety, with 0.22% of complications per session with liquid sclerosant and 0.58% with foamed sclerosant, but several points remain unclear, and more research is needed. Patient's informed consent can be better obtained thanks to the current knowledge herein summarized.
    MeSH term(s) France ; Humans ; Sclerosing Solutions/adverse effects ; Sclerotherapy/adverse effects
    Chemical Substances Sclerosing Solutions
    Language English
    Publishing date 2010-09-28
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1227586-4
    ISSN 1524-4725 ; 1076-0512
    ISSN (online) 1524-4725
    ISSN 1076-0512
    DOI 10.1111/j.1524-4725.2009.01409.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Patient-reported outcome or physician-reported outcome?

    Guex, Jean-Jérôme

    Phlebology

    2008  Volume 23, Issue 6, Page(s) 251

    MeSH term(s) Humans ; Physician-Patient Relations ; Quality Assurance, Health Care ; Quality of Life ; Treatment Outcome ; Vascular Diseases/pathology ; Vascular Diseases/therapy ; Veins/pathology
    Language English
    Publishing date 2008
    Publishing country England
    Document type Comment ; Editorial
    ZDB-ID 645172-x
    ISSN 1758-1125 ; 0268-3555
    ISSN (online) 1758-1125
    ISSN 0268-3555
    DOI 10.1258/phleb.2008.008067
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Book: Sclerotherapy

    Goldman, Mitchel P / Weiss, Robert A / Guex, Jean-Jérôme

    treatment of varicose and telangiectatic leg veins

    2017  

    Author's details editors, Mitchel P. Goldman, Robert A. Weiss ; contributors, Jean-Jé́rôme Guex, Hugo Partsch, Michel R. Perrin, Albert-Adrien Ramelet, Stefano Ricci, Oscar Maleti, Marzia Lugli
    MeSH term(s) Varicose Veins/therapy ; Sclerotherapy ; Telangiectasis/therapy
    Language English
    Size xiv, 444 pages :, illustrations
    Edition Sixth edition.
    Document type Book
    ISBN 9780323377263 ; 0323377262
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

  7. Article: Foam sclerotherapy: an overview of use for primary venous insufficiency.

    Guex, Jean-Jérôme

    Seminars in vascular surgery

    2005  Volume 18, Issue 1, Page(s) 25–29

    Abstract: Ultrasound-guided sclerotherapy with foam is able to suppress blood flow in almost all types of varicose veins. The technique is efficient, simple, safe, inexpensive, and easily repeatable, although it requires training and skill. It should be considered ...

    Abstract Ultrasound-guided sclerotherapy with foam is able to suppress blood flow in almost all types of varicose veins. The technique is efficient, simple, safe, inexpensive, and easily repeatable, although it requires training and skill. It should be considered as the best primary treatment for most varicose patients. Evaluation of long-term results, with regard to comparison with other techniques, should take into account all advantages and drawbacks and evaluate cost-effectiveness from a life-long point of view.
    MeSH term(s) Drug Combinations ; Follow-Up Studies ; Humans ; Injections, Intravenous ; Polidocanol ; Polyethylene Glycols/administration & dosage ; Polyethylene Glycols/therapeutic use ; Sclerosing Solutions/administration & dosage ; Sclerosing Solutions/therapeutic use ; Sclerotherapy/methods ; Sodium Tetradecyl Sulfate/administration & dosage ; Sodium Tetradecyl Sulfate/therapeutic use ; Time Factors ; Treatment Outcome ; Venous Insufficiency/therapy
    Chemical Substances Drug Combinations ; Sclerosing Solutions ; Polidocanol (0AWH8BFG9A) ; Polyethylene Glycols (3WJQ0SDW1A) ; Sodium Tetradecyl Sulfate (Q1SUG5KBD6)
    Language English
    Publishing date 2005-03-11
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 645131-7
    ISSN 1558-4518 ; 0895-7967
    ISSN (online) 1558-4518
    ISSN 0895-7967
    DOI 10.1053/j.semvascsurg.2004.12.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Sclerotherapy is a safe method of treatment of chronic venous disorders in older patients: A prospective and comparative study of consecutive patients.

    Gillet, Jean-Luc / Desnos, Claudine H / Lausecker, Michel / Daniel, Christian / Guex, Jean-Jerome / Allaert, François-André

    Phlebology

    2017  Volume 32, Issue 4, Page(s) 234–240

    Abstract: Objectives An aging population requires evaluation of methods of treatment for older patients. Our objective was to evaluate the indications, practical modalities, safety and tolerability of sclerotherapy in patients 75 years of age and older (group 1) ... ...

    Abstract Objectives An aging population requires evaluation of methods of treatment for older patients. Our objective was to evaluate the indications, practical modalities, safety and tolerability of sclerotherapy in patients 75 years of age and older (group 1) and compare with a control group of patients 18 to74 years of age (group 2). Method This observational, multicentre, prospective and comparative study was conducted by the French Society of Phlebology. Each centre collected in 10 to 20 patients ≥75 years of age and an equal number of patients <75 years of age treated by sclerotherapy, the treatment indication, the patient's personal history, the CEAP clinical class, the type of the veins being treated, the characteristics of sclerotherapy and the complications (immediately after treatment and at one-month follow-up). Results Population: In total, 418 patients were enrolled in 15 centres: 176 patients in group 1 (mean: 79.4 years) and 242 patients in group 2 (mean: 52.7 years).CEAP clinical classes C4, C5 and C6, history of deep vein thrombosis (12.5%) and superficial vein thrombosis (11.9%), long-term anticoagulant therapy (9.1%) and antiplatelet therapy (16.5%) were more frequent in older patients.All types of veins were treated from saphenous veins to telangiectasias. Sclerotherapy features: There was no difference in concentration of the sclerosing agents. When foam sclerotherapy was used (84% of patients), the injected volume was lower in group 1.
    Complications: One vasovagal syncope occurred in group 1. One asymptomatic distal deep vein thrombosis, confined to the Medial Gastrocnemius Veins, was reported in both groups at one-month follow-up. Conclusions This study shows the feasibility and safety of sclerotherapy in older patients, with no specific complications nor need for special precautions.
    MeSH term(s) Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anticoagulants/administration & dosage ; Chronic Disease ; Female ; Humans ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/administration & dosage ; Prospective Studies ; Sclerotherapy ; Varicose Veins/therapy ; Venous Thrombosis/therapy
    Chemical Substances Anticoagulants ; Platelet Aggregation Inhibitors
    Language English
    Publishing date 2017-05
    Publishing country England
    Document type Clinical Trial ; Comparative Study ; Journal Article ; Multicenter Study ; Observational Study
    ZDB-ID 645172-x
    ISSN 1758-1125 ; 0268-3555
    ISSN (online) 1758-1125
    ISSN 0268-3555
    DOI 10.1177/0268355516642659
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Book: Sclerotherapy

    Goldman, Mitchel P / Guex, Jean-Jérôme / Weiss, Robert A

    treatment of varicose and telangiectatic leg veins

    2011  

    MeSH term(s) Varicose Veins/therapy ; Sclerotherapy ; Telangiectasis/therapy
    Language English
    Size xiv, 401 p. :, col. ill. ;, 29 cm. +
    Edition 5th ed. /
    Publisher Saunders/ Elsevier
    Publishing place Edinburgh
    Document type Book
    Accompanying material 1 DVD-ROM (4 3/4 in.)
    ISBN 9780323073677 ; 0323073670
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

  10. Article ; Online: Sclerotherapy of lower limb veins: Indications, contraindications and treatment strategies to prevent complications - A consensus document of the International Union of Phlebology-2023.

    Wong, Mandy / Parsi, Kurosh / Myers, Kenneth / De Maeseneer, Marianne / Caprini, Joseph / Cavezzi, Attilio / Connor, David E / Davies, Alun H / Gianesini, Sergio / Gillet, Jean-Luc / Grondin, Louis / Guex, Jean-Jérôme / Hamel-Desnos, Claudine / Morrison, Nick / Mosti, Giovanni / Orrego, Alvaro / Partsch, Hugo / Rabe, Eberhard / Raymond-Martimbeau, Pauline /
    Schadeck, Michel / Simkin, Roberto / Tessari, Lorenzo / Thibault, Paul K / Ulloa, Jorge H / Whiteley, Mark / Yamaki, Takashi / Zimmet, Steven / Kang, Mina / Vuong, Selene / Yang, Anes / Zhang, Lois

    Phlebology

    2023  Volume 38, Issue 4, Page(s) 205–258

    Abstract: Background: Sclerotherapy is a non-invasive procedure commonly used to treat superficial venous disease, vascular malformations and other ectatic vascular lesions. While extremely rare, sclerotherapy may be complicated by serious adverse events.: ... ...

    Abstract Background: Sclerotherapy is a non-invasive procedure commonly used to treat superficial venous disease, vascular malformations and other ectatic vascular lesions. While extremely rare, sclerotherapy may be complicated by serious adverse events.
    Objectives: To categorise contraindications to sclerotherapy based on the available scientific evidence.
    Methods: An international, multi-disciplinary panel of phlebologists reviewed the available scientific evidence and developed consensus where evidence was lacking or limited.
    Results: Absolute Contraindications
    Conclusions: Sclerotherapy can achieve safe clinical outcomes provided that (1) patient-related risk factors and in particular all material risks are (1a) adequately identified and the risk benefit ratio is clearly and openly discussed with treatment candidates within a reasonable timeframe
    MeSH term(s) Pregnancy ; Female ; Humans ; Sclerotherapy/adverse effects ; Consensus ; Venous Thromboembolism/etiology ; Contraindications ; Lower Extremity
    Language English
    Publishing date 2023-03-14
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 645172-x
    ISSN 1758-1125 ; 0268-3555
    ISSN (online) 1758-1125
    ISSN 0268-3555
    DOI 10.1177/02683555231151350
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top